Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease
Z Liu, RA Khalil - Biochemical pharmacology, 2018 - Elsevier
Vascular smooth muscle (VSM) plays an important role in the regulation of vascular function.
Identifying the mechanisms of VSM contraction has been a major research goal in order to …
Identifying the mechanisms of VSM contraction has been a major research goal in order to …
Protein kinase C pharmacology: refining the toolbox
AX Wu-Zhang, AC Newton - Biochemical Journal, 2013 - portlandpress.com
PKC (protein kinase C) has been in the limelight since the discovery three decades ago that
it acts as a major receptor for the tumour-promoting phorbol esters. Phorbol esters, with their …
it acts as a major receptor for the tumour-promoting phorbol esters. Phorbol esters, with their …
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells
The epithelial-mesenchymal transition program becomes activated during malignant
progression and can enrich for cancer stem cells (CSCs). We report that inhibition of protein …
progression and can enrich for cancer stem cells (CSCs). We report that inhibition of protein …
mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif
The complex mTORC2 is accepted to be the kinase that controls the phosphorylation of the
hydrophobic motif, a key regulatory switch for AGC kinases, although whether mTOR directly …
hydrophobic motif, a key regulatory switch for AGC kinases, although whether mTOR directly …
Equivocal, explicit and emergent actions of PKC isoforms in cancer
PJ Parker, SJ Brown, V Calleja, P Chakravarty… - Nature Reviews …, 2021 - nature.com
The maturing mutational landscape of cancer genomes, the development and application of
clinical interventions and evolving insights into tumour-associated functions reveal …
clinical interventions and evolving insights into tumour-associated functions reveal …
CCR2 chemokine receptors enhance growth and cell-cycle progression of breast cancer cells through SRC and PKC activation
Basal-like breast cancers are an aggressive breast cancer subtype, which often lack
estrogen receptor, progesterone receptor, and Her2 expression, and are resistant to …
estrogen receptor, progesterone receptor, and Her2 expression, and are resistant to …
Protein kinase C quality control by phosphatase PHLPP1 unveils loss-of-function mechanism in cancer
Protein kinase C (PKC) isozymes function as tumor suppressors in increasing contexts. In
contrast to oncogenic kinases, whose function is acutely regulated by transient …
contrast to oncogenic kinases, whose function is acutely regulated by transient …
Intramolecular conformational changes optimize protein kinase C signaling
Optimal tuning of enzyme signaling is critical for cellular homeostasis. We use fluorescence
resonance energy transfer reporters in live cells to follow conformational transitions that tune …
resonance energy transfer reporters in live cells to follow conformational transitions that tune …
Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?
G Lordén, AC Newton - Neuronal signaling, 2021 - portlandpress.com
Abstract Protein Kinase C (PKC) isozymes are tightly regulated kinases that transduce a
myriad of signals from receptor-mediated hydrolysis of membrane phospholipids. They play …
myriad of signals from receptor-mediated hydrolysis of membrane phospholipids. They play …
Intramolecular C2 domain-mediated autoinhibition of protein kinase C βII
The signaling output of protein kinase C (PKC) is exquisitely controlled, with its disruption
resulting in pathophysiologies. Identifying the structural basis for autoinhibition is central to …
resulting in pathophysiologies. Identifying the structural basis for autoinhibition is central to …